Related Experiment Video
Updated: Nov 18, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
HAND2-AS1: A functional cancer-related long non-coding RNA
Xinyu Gu1, Qiuxian Zheng1, Qingfei Chu1
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China.
Long non-coding RNA HAND2-AS1 generally suppresses tumor growth, but its role varies by cancer type. Aberrant HAND2-AS1 expression impacts tumor progression, prognosis, and cellular processes, highlighting its clinical significance.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are key regulators of gene expression and carcinogenesis.
- The lncRNA HAND2-AS1 (heart and neural crest derivatives expressed transcript 2 antisense RNA 1) has a complex role in cancer, often acting as a tumor suppressor.
- Its expression is frequently decreased in various cancers, but paradoxically upregulated in hepatocellular carcinoma, suggesting context-dependent functions.
Purpose of the Study:
- To review the expression profile, functions, underlying mechanisms, and clinical value of HAND2-AS1 in human cancers.
- To consolidate current knowledge on HAND2-AS1's involvement in tumor progression and prognosis.
- To analyze the expression patterns of HAND2-AS1 across a wide range of cancer types.
Main Methods:
- Literature review of studies investigating HAND2-AS1 in cancer.
- Bioinformatic analysis of HAND2-AS1 expression data from The Cancer Genome Atlas (TCGA) across 33 tumor types.
- Synthesis of data on HAND2-AS1's functional roles in proliferation, apoptosis, and metabolism.
Main Results:
- HAND2-AS1 expression is downregulated in most analyzed cancers (e.g., lung, ovarian, breast, gastric, colorectal, cervical, endometrial, prostate, esophagus).
- Conversely, HAND2-AS1 is upregulated in hepatocellular carcinoma, where it promotes tumor development.
- Aberrant HAND2-AS1 expression correlates significantly with tumor progression and patient prognosis.
- HAND2-AS1 influences critical cancer hallmarks including cell proliferation, differentiation, apoptosis, and glucose metabolism.
Conclusions:
- HAND2-AS1 exhibits diverse expression patterns and functions across different cancer types.
- Its dysregulation is closely linked to cancer development and clinical outcomes.
- HAND2-AS1 represents a potential biomarker and therapeutic target in oncology.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
RNA Splicing
